IDEX (IEX) Financials

$181.79 +0.34 (+0.19%)

Closing price 03:59 PM Eastern

Extended Trading

$181.70 -0.09 (-0.05%)

As of 07:35 PM Eastern

Annual Income Statements for IDEX

This table shows IDEX's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	283	271	337	411	426	378	449	587	596	505
Consolidated Net Income / (Loss)	283	271	337	411	426	378	449	587	596	505
Net Income / (Loss) Continuing Operations	283	271	337	411	426	378	449	587	596	505
Total Pre-Tax Income	392	369	455	529	533	470	580	749	760	639
Total Operating Income	419	435	493	569	579	521	637	751	733	677
Total Gross Profit	904	931	1,027	1,118	1,125	1,027	1,225	1,427	1,447	1,445
Total Revenue	2,021	2,113	2,287	2,484	2,495	2,352	2,765	3,182	3,274	3,269
Operating Revenue	2,021	2,113	2,287	2,484	2,495	2,352	2,765	3,182	3,274	3,269
Total Cost of Revenue	1,116	1,182	1,261	1,366	1,370	1,324	1,540	1,755	1,827	1,824
Operating Cost of Revenue	1,116	1,182	1,261	1,366	1,370	1,324	1,540	1,755	1,827	1,824
Total Operating Expenses	485	496	533	549	546	507	588	676	714	768
Selling, General & Admin Expense	474	492	525	537	525	495	578	653	704	759
Restructuring Charge	11	3.67	8.46	12	21	12	9.30	23	11	9.30
Total Other Income / (Expense), net	-27	-66	-38	-40	-46	-50	-57	-2.00	28	-38
Interest & Investment Income	-	-	-	-	-	-	-	-41	-52	-45
Other Income / (Expense), net	15	-21	6.88	3.99	-1.80	-5.60	-16	39	80	6.60
Income Tax Expense	110	97	118	118	107	93	131	163	165	135
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	-	-	0.00	0.00	-0.10	-0.20	-0.50	-0.40
Basic Earnings per Share	$3.65	$3.57	$4.41	$5.36	$5.62	$4.98	$5.91	$7.74	$7.87	$6.66
Weighted Average Basic Shares Outstanding	77.13M	75.80M	76.23M	76.41M	75.60M	75.70M	76M	75.70M	75.60M	75.70M
Diluted Earnings per Share	$3.62	$3.53	$4.36	$5.29	$5.56	$4.94	$5.88	$7.71	$7.85	$6.64
Weighted Average Diluted Shares Outstanding	77.97M	76.76M	77.33M	77.56M	76.50M	76.40M	76.40M	76M	75.90M	75.90M
Weighted Average Basic & Diluted Shares Outstanding	77.50M	75.90M	76.50M	76.60M	76.21M	75.89M	76.12M	75.52M	75.64M	75.78M
Cash Dividends to Common per Share	$1.28	$1.36	$1.48	$1.72	$2.00	$2.00	$2.16	$2.40	$2.56	$2.76

This table shows IDEX's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	179	130	140	139	209	109	121	141	119	123
Consolidated Net Income / (Loss)	179	130	140	139	209	108	121	141	119	123
Net Income / (Loss) Continuing Operations	179	130	140	139	209	108	121	141	119	123
Total Pre-Tax Income	228	164	180	179	262	140	155	179	154	151
Total Operating Income	202	175	192	200	180	161	161	183	168	165
Total Gross Profit	382	346	383	378	350	337	357	367	354	367
Total Revenue	824	811	845	846	793	789	801	807	798	863
Operating Revenue	824	811	845	846	793	789	801	807	798	863
Total Cost of Revenue	442	465	463	468	444	452	443	440	444	496
Operating Cost of Revenue	442	465	463	468	444	452	443	440	444	496
Total Operating Expenses	180	171	190	178	170	176	196	184	186	202
Selling, General & Admin Expense	162	169	190	174	166	174	195	183	183	198
Restructuring Charge	18	1.70	0.50	3.60	4.10	2.70	1.10	1.30	3.00	3.90
Total Other Income / (Expense), net	26	-12	-13	-22	82	-20	-6.70	-3.50	-14	-14
Other Income / (Expense), net	36	0.60	0.60	-8.30	96	-8.70	2.70	4.60	-3.30	2.60
Income Tax Expense	50	34	40	40	53	32	33	38	36	28
Basic Earnings per Share	$2.37	$1.71	$1.85	$1.83	$2.76	$1.43	$1.60	$1.86	$1.57	$1.63
Weighted Average Basic Shares Outstanding	75.40M	75.70M	75.60M	75.60M	75.60M	75.60M	75.70M	75.70M	75.70M	75.70M
Diluted Earnings per Share	$2.36	$1.71	$1.84	$1.82	$2.75	$1.44	$1.60	$1.86	$1.57	$1.61
Weighted Average Diluted Shares Outstanding	75.80M	76M	75.90M	75.90M	75.90M	75.90M	75.90M	75.90M	75.90M	75.90M
Weighted Average Basic & Diluted Shares Outstanding	75.42M	75.52M	75.58M	75.60M	75.63M	75.64M	75.70M	75.70M	75.72M	75.78M

This table details how cash moves in and out of IDEX's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-181	-92	140	90	166	393	-171	-425	104	105
Net Cash From Operating Activities	360	400	433	479	528	569	565	557	717	668
Net Cash From Continuing Operating Activities	360	400	433	479	528	569	565	557	717	668
Net Income / (Loss) Continuing Operations	283	271	337	411	426	378	449	587	596	505
Consolidated Net Income / (Loss)	283	271	337	411	426	378	449	587	596	505
Depreciation Expense	36	38	38	39	40	42	47	51	57	69
Amortization Expense	44	50	47	40	39	44	56	69	95	107
Non-Cash Adjustments To Reconcile Net Income	4.42	53	22	32	39	24	33	4.20	-54	22
Changes in Operating Assets and Liabilities, net	-6.64	-13	-12	-42	-14	82	-20	-153	23	-34
Net Cash From Investing Activities	-210	-509	-55	-81	-137	-173	-698	-917	-284	-1,007
Net Cash From Continuing Investing Activities	-210	-509	-55	-81	-137	-173	-698	-917	-284	-1,007
Purchase of Property, Plant & Equipment	-44	-38	-44	-56	-51	-52	-73	-68	-90	-65
Acquisitions	-195	-510	-38	-24	-87	-123	-577	-946	-312	-985
Purchase of Investments	-	-	-	-	-	0.00	-45	0.00	-29	0.00
Divestitures	28	39	22	0.00	-	0.00	0.00	49	119	45
Sale and/or Maturity of Investments	-	-	-	-	-	0.00	0.00	40	25	4.50
Other Investing Activities, net	0.62	-0.02	5.48	-1.50	1.10	2.10	-2.80	7.30	3.50	-6.50
Net Cash From Financing Activities	-296	47	-277	-290	-228	-43	-9.50	-38	-345	466
Net Cash From Continuing Financing Activities	-296	47	-277	-290	-228	-43	-9.50	-38	-345	466
Repayment of Debt	-424	-520	-201	-11	-52	-455	-355	-137	-251	-122
Repurchase of Common Equity	-211	-57	-29	-174	-55	-110	0.00	-148	-24	0.00
Payment of Dividends	-96	-103	-111	-127	-147	-152	-161	-177	-191	-205
Issuance of Debt	414	702	33	0.00	-	649	499	410	100	776
Issuance of Common Equity	-	-	-	-	-	0.00	14	14	22	17
Other Net Changes in Cash	-	-	-	-	2.70	39	-28	-	-	-23
Cash Interest Paid	34	37	37	36	37	35	36	37	51	47
Cash Income Taxes Paid	113	109	105	91	109	87	118	176	200	171

This table details how cash moves in and out of IDEX's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	123	-251	81	-54	106	-28	82	84	-49	-12
Net Cash From Operating Activities	198	167	148	141	227	201	157	134	205	173
Net Cash From Continuing Operating Activities	198	167	148	141	227	201	157	134	205	173
Net Income / (Loss) Continuing Operations	179	130	140	139	209	108	121	141	119	123
Consolidated Net Income / (Loss)	179	130	140	139	209	108	121	141	119	123
Depreciation Expense	12	14	13	14	15	15	16	16	17	19
Amortization Expense	16	20	24	23	24	24	25	24	27	32
Non-Cash Adjustments To Reconcile Net Income	-13	5.60	13	12	-92	13	13	-0.20	4.60	5.00
Changes in Operating Assets and Liabilities, net	3.40	-1.80	-41	-47	71	40	-18	-48	38	-6.30
Net Cash From Investing Activities	36	-693	-29	-147	87	-194	-20	32	-1,004	-15
Net Cash From Continuing Investing Activities	36	-693	-29	-147	87	-194	-20	32	-1,004	-15
Purchase of Property, Plant & Equipment	-16	-20	-27	-22	-20	-22	-20	-16	-14	-16
Other Investing Activities, net	6.90	0.50	0.60	0.40	1.90	0.60	0.00	0.50	-7.80	0.80
Net Cash From Financing Activities	-78	237	-45	-47	-195	-58	-41	-77	725	-141
Net Cash From Continuing Financing Activities	-78	237	-45	-47	-195	-58	-41	-77	725	-141
Repayment of Debt	-40	-97	0.00	-101	-151	-0.30	-0.20	-25	-1.40	-95
Payment of Dividends	-45	-45	-46	-48	-48	-48	-49	-52	-52	-52
Issuance of Common Equity	-	-	0.30	3.10	4.30	14	7.70	0.20	2.60	6.20
Cash Interest Paid	0.40	18	4.10	21	5.40	20	2.40	21	2.50	22
Cash Income Taxes Paid	43	46	21	82	44	52	18	66	36	51

This table presents IDEX's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	2,805	3,155	3,400	3,474	3,814	4,414	4,917	5,512	5,865	6,745
Total Current Assets	863	823	1,004	1,093	1,261	1,657	1,678	1,399	1,446	1,593
Cash & Equivalents	328	236	376	466	633	1,026	855	430	534	621
Accounts Receivable	260	273	294	312	298	293	356	443	428	466
Inventories, net	239	253	260	280	293	290	370	471	421	430
Other Current Assets	36	61	74	34	37	48	96	55	63	76
Plant, Property, & Equipment, net	241	248	258	281	280	298	327	382	430	460
Total Noncurrent Assets	1,702	2,084	2,137	2,100	2,272	2,459	2,912	3,731	3,989	4,692
Goodwill	1,397	1,633	1,704	1,698	1,780	1,896	2,168	2,638	2,838	3,252
Intangible Assets	288	436	415	383	388	416	597	948	1,012	1,285
Other Noncurrent Operating Assets	17	16	18	19	104	148	147	145	139	156
Total Liabilities & Shareholders' Equity	2,805	3,155	3,400	3,474	3,814	4,414	4,917	5,512	5,865	6,745
Total Liabilities	1,362	1,611	1,513	1,479	1,551	1,874	2,114	2,472	2,324	2,951
Total Current Liabilities	310	309	361	365	358	399	480	544	500	630
Short-Term Debt	-	-	-	0.48	0.39	0.10	-	0.00	0.60	101
Accounts Payable	129	129	147	143	138	152	179	209	180	198
Accrued Expenses	154	153	185	188	180	209	260	289	272	279
Dividends Payable	26	26	29	33	39	38	41	46	49	53
Total Noncurrent Liabilities	1,053	1,302	1,152	1,115	1,193	1,475	1,634	1,929	1,824	2,322
Long-Term Debt	840	1,014	859	848	849	1,044	1,190	1,469	1,325	1,860
Noncurrent Deferred & Payable Income Tax Liabilities	110	166	138	128	147	164	196	264	292	267
Other Noncurrent Operating Liabilities	102	121	156	138	197	267	247	196	207	195
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,443	1,544	1,887	1,995	2,263	2,540	2,803	3,040	3,541	3,794
Total Preferred & Common Equity	1,443	1,544	1,887	1,995	2,263	2,540	2,803	3,039	3,541	3,795
Preferred Stock	-	-	-	0.00	0.00	0.00	-	0.00	0.00	0.00
Total Common Equity	1,443	1,544	1,887	1,995	2,263	2,540	2,803	3,039	3,541	3,795
Common Stock	681	698	718	739	761	776	797	818	840	866
Retained Earnings	1,667	1,835	2,058	2,342	2,615	2,842	3,127	3,532	3,934	4,230
Treasury Stock	-757	-787	-800	-957	-986	-1,064	-1,050	-1,184	-1,187	-1,170
Accumulated Other Comprehensive Income / (Loss)	-146	-202	-90	-129	-127	-14	-70	-126	-46	-131
Noncontrolling Interest	-	-	-	-	0.00	0.10	0.00	0.30	-0.20	-0.60

This table presents IDEX's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Total Assets	4,893	5,512	5,658	5,720	5,670	5,865	5,889	5,903	6,968	6,745
Total Current Assets	1,635	1,399	1,525	1,488	1,518	1,446	1,555	1,630	1,678	1,593
Cash & Equivalents	681	430	511	457	563	534	616	701	633	621
Accounts Receivable	406	443	447	455	431	428	438	426	475	466
Inventories, net	455	471	498	483	447	421	426	428	488	430
Other Current Assets	93	55	70	93	78	63	74	75	81	76
Plant, Property, & Equipment, net	304	382	397	422	422	430	428	419	469	460
Total Noncurrent Assets	2,954	3,731	3,737	3,810	3,730	3,989	3,907	3,855	4,821	4,692
Goodwill	2,191	2,638	2,658	2,714	2,677	2,838	2,803	2,787	3,316	3,252
Intangible Assets	629	948	934	957	920	1,012	969	931	1,349	1,285
Other Noncurrent Operating Assets	134	145	145	139	133	139	135	137	156	156
Total Liabilities & Shareholders' Equity	4,893	5,512	5,658	5,720	5,670	5,865	5,889	5,903	6,968	6,745
Total Liabilities	2,090	2,472	2,429	2,441	2,282	2,324	2,271	2,250	3,149	2,951
Total Current Liabilities	507	544	492	487	488	500	461	477	565	630
Short-Term Debt	-	0.00	-	0.50	0.70	0.60	0.70	0.60	0.60	101
Accounts Payable	197	209	216	190	176	180	186	172	210	198
Accrued Expenses	265	289	276	248	262	272	274	252	301	279
Dividends Payable	45	46	0.00	49	49	49	0.00	52	52	53
Total Noncurrent Liabilities	1,584	1,929	1,937	1,954	1,795	1,824	1,811	1,773	2,585	2,322
Long-Term Debt	1,191	1,469	1,471	1,472	1,321	1,325	1,323	1,297	2,075	1,860
Noncurrent Deferred & Payable Income Tax Liabilities	186	264	267	286	279	292	286	281	301	267
Other Noncurrent Operating Liabilities	207	196	199	197	195	207	202	194	208	195
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,803	3,040	3,230	3,279	3,387	3,541	3,618	3,653	3,818	3,794
Total Preferred & Common Equity	2,803	3,039	3,229	3,279	3,387	3,541	3,619	3,654	3,819	3,795
Preferred Stock	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,803	3,039	3,229	3,279	3,387	3,541	3,619	3,654	3,819	3,795
Common Stock	813	818	831	835	837	840	852	857	861	866
Retained Earnings	3,447	3,532	3,672	3,713	3,874	3,934	4,056	4,093	4,159	4,230
Treasury Stock	-1,193	-1,184	-1,184	-1,182	-1,178	-1,187	-1,179	-1,179	-1,177	-1,170
Accumulated Other Comprehensive Income / (Loss)	-264	-126	-89	-88	-146	-46	-110	-116	-25	-131
Noncontrolling Interest	-0.20	0.30	0.30	0.20	0.10	-0.20	-0.30	-0.40	-0.60	-0.60

This table displays calculated financial ratios and metrics derived from IDEX's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-5.92%	4.57%	8.25%	8.58%	0.44%	-5.73%	17.57%	15.09%	2.89%	-0.16%
EBITDA Growth	0.15%	-2.22%	16.60%	11.31%	0.54%	-8.42%	20.57%	25.70%	5.97%	-10.86%
EBIT Growth	-0.08%	-4.57%	20.77%	14.58%	0.72%	-10.76%	20.52%	27.27%	2.77%	-15.79%
NOPAT Growth	-1.64%	5.91%	14.26%	20.89%	4.66%	-9.52%	18.01%	19.17%	-2.46%	-6.85%
Net Income Growth	1.22%	-4.14%	24.40%	21.74%	3.64%	-11.21%	18.93%	30.58%	1.52%	-15.28%
EPS Growth	4.93%	-2.49%	23.51%	21.33%	5.10%	-11.15%	19.03%	31.12%	1.82%	-15.41%
Operating Cash Flow Growth	-2.08%	10.99%	8.21%	10.77%	10.17%	7.80%	-0.70%	-1.40%	28.58%	-6.78%
Free Cash Flow Firm Growth	-52.21%	-126.71%	762.62%	35.86%	-17.60%	-4.02%	-126.12%	-301.05%	188.87%	-185.45%
Invested Capital Growth	6.63%	18.54%	2.09%	0.50%	4.49%	3.11%	22.43%	29.70%	6.24%	18.37%
Revenue Q/Q Growth	-1.18%	1.47%	2.49%	1.15%	-0.32%	0.37%	3.75%	3.11%	-0.66%	2.32%
EBITDA Q/Q Growth	0.88%	-2.33%	8.90%	0.49%	-0.83%	1.61%	4.15%	1.98%	-1.80%	3.27%
EBIT Q/Q Growth	0.70%	-3.31%	11.06%	0.93%	-1.16%	1.50%	3.70%	1.65%	-2.85%	2.41%
NOPAT Q/Q Growth	-0.79%	5.92%	3.38%	2.51%	0.05%	0.39%	3.63%	2.33%	-2.49%	1.99%
Net Income Q/Q Growth	2.22%	-3.70%	12.10%	1.08%	-0.31%	1.14%	4.08%	1.96%	-3.52%	3.04%
EPS Q/Q Growth	2.55%	-3.55%	12.08%	1.15%	0.00%	0.82%	4.26%	2.12%	-3.33%	2.63%
Operating Cash Flow Q/Q Growth	-0.78%	4.45%	4.99%	3.77%	-0.45%	1.82%	0.30%	0.76%	4.93%	-4.08%
Free Cash Flow Firm Q/Q Growth	-21.82%	65.94%	-17.81%	9.96%	-6.42%	-2.89%	-20.23%	-196.86%	227.73%	54.53%
Invested Capital Q/Q Growth	-0.90%	-3.79%	-0.50%	-1.64%	-0.62%	-0.15%	0.90%	22.79%	4.45%	-2.39%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	44.75%	44.05%	44.89%	45.01%	45.10%	43.69%	44.29%	44.84%	44.20%	44.21%
EBITDA Margin	25.42%	23.77%	25.61%	26.25%	26.28%	25.53%	26.18%	28.59%	29.45%	26.29%
Operating Margin	20.73%	20.57%	21.57%	22.91%	23.21%	22.14%	23.04%	23.61%	22.37%	20.72%
EBIT Margin	21.48%	19.60%	21.87%	23.07%	23.14%	21.90%	22.45%	24.83%	24.80%	20.92%
Profit (Net Income) Margin	14.00%	12.83%	14.74%	16.53%	17.06%	16.07%	16.25%	18.44%	18.19%	15.44%
Tax Burden Percent	72.08%	73.57%	74.08%	77.62%	79.85%	80.33%	77.49%	78.29%	78.34%	78.93%
Interest Burden Percent	90.41%	88.99%	91.03%	92.30%	92.33%	91.30%	93.40%	94.85%	93.63%	93.49%
Effective Tax Rate	27.92%	26.43%	25.92%	22.38%	20.15%	19.67%	22.51%	21.71%	21.66%	21.07%
Return on Invested Capital (ROIC)	15.72%	14.77%	15.39%	18.37%	18.76%	16.35%	17.09%	16.11%	13.49%	11.17%
ROIC Less NNEP Spread (ROIC-NNEP)	11.52%	7.52%	11.12%	11.65%	7.79%	-9.59%	-3.38%	15.90%	15.76%	8.49%
Return on Net Nonoperating Assets (RNNOA)	3.58%	3.39%	4.27%	2.79%	1.23%	-0.62%	-0.27%	3.97%	4.61%	2.58%
Return on Equity (ROE)	19.31%	18.15%	19.66%	21.16%	19.99%	15.73%	16.82%	20.08%	18.10%	13.76%
Cash Return on Invested Capital (CROIC)	9.31%	-2.20%	13.33%	17.88%	14.37%	13.29%	-3.07%	-9.75%	7.44%	-5.65%
Operating Return on Assets (OROA)	15.20%	13.90%	15.26%	16.67%	15.84%	12.52%	13.31%	15.15%	14.27%	10.84%
Return on Assets (ROA)	9.91%	9.10%	10.29%	11.95%	11.68%	9.18%	9.63%	11.25%	10.47%	8.00%
Return on Common Equity (ROCE)	19.31%	18.15%	19.66%	21.16%	19.99%	15.73%	16.82%	20.08%	18.10%	13.76%
Return on Equity Simple (ROE_SIMPLE)	19.59%	17.56%	17.88%	20.58%	18.80%	14.87%	16.03%	19.30%	16.82%	13.30%
Net Operating Profit after Tax (NOPAT)	302	320	365	442	462	418	494	588	574	535
NOPAT Margin	14.94%	15.13%	15.98%	17.79%	18.53%	17.79%	17.85%	18.49%	17.53%	16.35%
Net Nonoperating Expense Percent (NNEP)	4.21%	7.24%	4.27%	6.72%	10.97%	25.94%	20.47%	0.21%	-2.26%	2.68%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	13.05%	11.79%	9.29%
Cost of Revenue to Revenue	55.25%	55.95%	55.11%	54.99%	54.90%	56.31%	55.71%	55.16%	55.81%	55.79%
SG&A Expenses to Revenue	23.47%	23.30%	22.95%	21.61%	21.05%	21.05%	20.91%	20.51%	21.49%	23.21%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	24.02%	23.48%	23.32%	22.10%	21.89%	21.55%	21.25%	21.23%	21.82%	23.49%
Earnings before Interest and Taxes (EBIT)	434	414	500	573	577	515	621	790	812	684
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	514	502	586	652	656	600	724	910	964	859
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.64	4.05	4.93	4.54	5.47	5.69	6.20	5.51	4.56	4.16
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	129.71	63.08	456.23	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.60	2.96	4.07	3.64	4.96	6.14	6.29	5.26	4.94	4.83
Price to Earnings (P/E)	18.57	23.07	27.60	22.05	29.10	38.24	38.68	28.54	27.11	31.28
Dividend Yield	1.81%	1.63%	1.19%	1.41%	1.19%	1.05%	0.93%	1.05%	1.18%	1.30%
Earnings Yield	5.38%	4.33%	3.62%	4.54%	3.44%	2.62%	2.59%	3.50%	3.69%	3.20%
Enterprise Value to Invested Capital (EV/IC)	2.91	2.99	4.08	3.91	5.00	5.57	5.57	4.31	3.87	3.30
Enterprise Value to Revenue (EV/Rev)	2.85	3.33	4.28	3.80	5.05	6.15	6.41	5.59	5.18	5.24
Enterprise Value to EBITDA (EV/EBITDA)	11.22	14.00	16.72	14.47	19.22	24.09	24.48	19.55	17.58	19.94
Enterprise Value to EBIT (EV/EBIT)	13.28	16.98	19.58	16.46	21.83	28.08	28.54	22.52	20.87	25.06
Enterprise Value to NOPAT (EV/NOPAT)	19.09	21.99	26.80	21.36	27.25	34.58	35.89	30.24	29.54	32.06
Enterprise Value to Operating Cash Flow (EV/OCF)	16.00	17.59	22.63	19.68	23.85	25.41	31.34	31.91	23.65	25.65
Enterprise Value to Free Cash Flow (EV/FCFF)	32.25	0.00	30.95	21.95	35.57	42.55	0.00	0.00	53.56	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.58	0.66	0.46	0.43	0.38	0.41	0.42	0.48	0.37	0.52
Long-Term Debt to Equity	0.58	0.66	0.46	0.43	0.38	0.41	0.42	0.48	0.37	0.49
Financial Leverage	0.31	0.45	0.38	0.24	0.16	0.07	0.08	0.25	0.29	0.30
Leverage Ratio	1.95	2.00	1.91	1.77	1.71	1.71	1.75	1.79	1.73	1.72
Compound Leverage Factor	1.76	1.78	1.74	1.63	1.58	1.56	1.63	1.69	1.62	1.61
Debt to Total Capital	36.78%	39.65%	31.28%	29.85%	27.29%	29.14%	29.81%	32.58%	27.24%	34.07%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.02%	0.01%	0.00%	0.00%	0.00%	0.01%	1.75%
Long-Term Debt to Total Capital	36.78%	39.65%	31.28%	29.83%	27.27%	29.13%	29.81%	32.58%	27.23%	32.32%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.00%	-0.01%
Common Equity to Total Capital	63.22%	60.35%	68.72%	70.15%	72.71%	70.86%	70.19%	67.42%	72.77%	65.95%
Debt to EBITDA	1.63	2.02	1.47	1.30	1.30	1.74	1.64	1.61	1.38	2.28
Net Debt to EBITDA	1.00	1.55	0.82	0.59	0.33	0.03	0.46	1.14	0.82	1.56
Long-Term Debt to EBITDA	1.63	2.02	1.47	1.30	1.30	1.74	1.64	1.61	1.37	2.16
Debt to NOPAT	2.78	3.17	2.35	1.92	1.84	2.50	2.41	2.50	2.31	3.67
Net Debt to NOPAT	1.69	2.43	1.32	0.87	0.47	0.04	0.68	1.77	1.38	2.51
Long-Term Debt to NOPAT	2.78	3.17	2.35	1.92	1.84	2.50	2.41	2.50	2.31	3.48
Altman Z-Score	4.61	4.44	5.92	6.13	7.19	6.79	7.09	6.20	6.32	5.08
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.00%	-0.01%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.79	2.66	2.78	3.00	3.52	4.15	3.50	2.57	2.89	2.53
Quick Ratio	1.90	1.65	1.86	2.14	2.60	3.31	2.52	1.61	1.92	1.73
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	179	-48	316	430	354	340	-89	-356	316	-270
Operating Cash Flow to CapEx	823.10%	1,045.75%	986.71%	860.18%	1,037.52%	1,103.29%	777.58%	819.71%	797.22%	1,026.27%
Free Cash Flow to Firm to Interest Expense	4.29	-1.05	7.05	9.74	7.99	7.59	-2.17	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	8.65	8.77	9.64	10.86	11.92	12.71	13.79	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	7.60	7.93	8.66	9.60	10.77	11.56	12.01	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.71	0.71	0.70	0.72	0.68	0.57	0.59	0.61	0.58	0.52
Accounts Receivable Turnover	7.83	7.93	8.07	8.19	8.17	7.95	8.51	7.96	7.52	7.32
Inventory Turnover	4.68	4.81	4.92	5.06	4.78	4.54	4.67	4.17	4.10	4.29
Fixed Asset Turnover	8.78	8.65	9.04	9.21	8.88	8.13	8.84	8.97	8.06	7.34
Accounts Payable Turnover	8.71	9.17	9.14	9.41	9.73	9.12	9.31	9.05	9.40	9.66
Days Sales Outstanding (DSO)	46.61	46.02	45.24	44.56	44.65	45.89	42.87	45.84	48.53	49.90
Days Inventory Outstanding (DIO)	77.94	75.94	74.21	72.12	76.41	80.40	78.23	87.49	89.07	85.12
Days Payable Outstanding (DPO)	41.91	39.80	39.96	38.79	37.53	40.03	39.19	40.32	38.82	37.78
Cash Conversion Cycle (CCC)	82.63	82.16	79.49	77.89	83.54	86.26	81.91	93.01	98.79	97.23
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,982	2,350	2,399	2,410	2,519	2,597	3,179	4,124	4,381	5,186
Invested Capital Turnover	1.05	0.98	0.96	1.03	1.01	0.92	0.96	0.87	0.77	0.68
Increase / (Decrease) in Invested Capital	123	368	49	12	108	78	582	944	257	805
Enterprise Value (EV)	5,765	7,033	9,793	9,434	12,598	14,464	17,717	17,789	16,949	17,137
Market Capitalization	5,253	6,255	9,310	9,052	12,381	14,445	17,382	16,750	16,158	15,798
Book Value per Share	$18.86	$20.25	$24.69	$26.00	$29.76	$33.55	$36.87	$40.30	$46.83	$50.11
Tangible Book Value per Share	($3.15)	($6.88)	($3.04)	($1.13)	$1.26	$3.02	$0.50	($7.25)	($4.08)	($9.80)
Total Capital	2,283	2,558	2,745	2,843	3,112	3,585	3,993	4,508	4,867	5,754
Total Debt	840	1,014	859	849	849	1,045	1,190	1,469	1,326	1,960
Total Long-Term Debt	840	1,014	859	848	849	1,044	1,190	1,469	1,325	1,860
Net Debt	512	778	483	382	217	19	335	1,039	791	1,339
Capital Expenditures (CapEx)	44	38	44	56	51	52	73	68	90	65
Debt-free, Cash-free Net Working Capital (DFCFNWC)	225	278	267	262	271	232	343	426	412	443
Debt-free Net Working Capital (DFNWC)	553	514	643	728	904	1,258	1,198	856	947	1,064
Net Working Capital (NWC)	553	514	643	728	904	1,258	1,198	856	946	963
Net Nonoperating Expense (NNE)	19	49	28	31	37	40	44	1.57	-22	30
Net Nonoperating Obligations (NNO)	539	806	512	416	255	57	376	1,084	840	1,392
Total Depreciation and Amortization (D&A)	80	88	86	79	78	85	103	120	152	176
Debt-free, Cash-free Net Working Capital to Revenue	11.14%	13.14%	11.68%	10.55%	10.88%	9.88%	12.39%	13.37%	12.59%	13.55%
Debt-free Net Working Capital to Revenue	27.37%	24.30%	28.11%	29.33%	36.24%	53.51%	43.33%	26.89%	28.91%	32.54%
Net Working Capital to Revenue	27.37%	24.30%	28.11%	29.31%	36.22%	53.50%	43.33%	26.89%	28.90%	29.46%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.65	$3.57	$4.41	$5.36	$5.62	$4.98	$5.91	$7.74	$7.87	$6.66
Adjusted Weighted Average Basic Shares Outstanding	77.13M	75.80M	76.23M	76.41M	75.59M	75.74M	76M	75.70M	75.60M	75.70M
Adjusted Diluted Earnings per Share	$3.62	$3.53	$4.36	$5.29	$5.56	$4.94	$5.88	$7.71	$7.85	$6.64
Adjusted Weighted Average Diluted Shares Outstanding	77.97M	76.76M	77.33M	77.56M	76.45M	76.40M	76.40M	76M	75.90M	75.90M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	75.93M	76.25M	76.54M	75.79M	76.21M	75.89M	76.12M	75.52M	75.64M	75.78M
Normalized Net Operating Profit after Tax (NOPAT)	310	323	372	451	479	428	501	606	582	542
Normalized NOPAT Margin	15.34%	15.26%	16.25%	18.16%	19.20%	18.19%	18.11%	19.05%	17.79%	16.58%
Pre Tax Income Margin	19.42%	17.44%	19.90%	21.30%	21.36%	20.00%	20.97%	23.55%	23.22%	19.56%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	10.42	9.08	11.14	12.98	13.03	11.50	15.14	0.00	0.00	0.00
NOPAT to Interest Expense	7.25	7.01	8.14	10.01	10.44	9.34	12.04	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	9.37	8.24	10.17	11.72	11.88	10.35	13.37	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	6.20	6.17	7.16	8.75	9.29	8.19	10.27	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	34.01%	37.86%	32.96%	31.05%	34.59%	40.18%	35.86%	30.24%	32.02%	40.69%
Augmented Payout Ratio	108.55%	58.99%	41.58%	73.41%	47.45%	69.38%	35.86%	55.48%	36.08%	40.69%

This table displays calculated financial ratios and metrics derived from IDEX's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	15.73%	13.42%	12.55%	6.29%	-3.71%	-2.69%	-5.31%	-4.61%	0.61%	9.38%
EBITDA Growth	41.76%	9.25%	5.28%	6.01%	17.82%	-8.46%	-10.73%	-0.83%	-33.57%	14.21%
EBIT Growth	48.19%	7.86%	1.58%	2.79%	15.76%	-13.55%	-15.03%	-2.35%	-40.22%	10.61%
NOPAT Growth	28.17%	10.86%	2.77%	6.70%	-9.37%	-10.90%	-15.36%	-7.28%	-9.77%	8.64%
Net Income Growth	54.45%	9.52%	-0.07%	0.29%	16.96%	-16.69%	-13.23%	1.95%	-43.11%	13.76%
EPS Growth	56.29%	10.32%	0.55%	0.55%	16.53%	-15.79%	-13.04%	2.20%	-42.91%	11.81%
Operating Cash Flow Growth	26.50%	2.58%	85.57%	25.73%	14.39%	20.14%	5.88%	-5.38%	-9.40%	-14.13%
Free Cash Flow Firm Growth	88.50%	-76.23%	-32.93%	-447.84%	-1,311.54%	83.43%	98.60%	125.44%	-42.80%	-402.34%
Invested Capital Growth	6.58%	29.70%	24.83%	25.27%	24.90%	6.24%	3.25%	-0.91%	26.67%	18.37%
Revenue Q/Q Growth	3.50%	-1.61%	4.28%	0.09%	-6.24%	-0.57%	1.47%	0.84%	-1.12%	8.11%
EBITDA Q/Q Growth	23.15%	-21.54%	9.66%	0.04%	36.88%	-39.04%	6.95%	11.14%	-8.31%	4.79%
EBIT Q/Q Growth	27.55%	-26.22%	9.85%	-0.57%	43.64%	-44.90%	7.97%	14.28%	-12.07%	1.94%
NOPAT Q/Q Growth	8.72%	-12.05%	7.46%	3.84%	-7.65%	-13.53%	2.08%	13.75%	-10.13%	4.11%
Net Income Q/Q Growth	29.40%	-27.25%	7.54%	-0.93%	50.90%	-48.18%	12.00%	16.41%	-15.79%	3.62%
EPS Q/Q Growth	30.39%	-27.54%	7.60%	-1.09%	51.10%	-47.64%	11.11%	16.25%	-15.59%	2.55%
Operating Cash Flow Q/Q Growth	76.40%	-15.55%	-11.60%	-4.53%	60.48%	-11.30%	-22.09%	-14.69%	53.67%	-15.93%
Free Cash Flow Firm Q/Q Growth	62.69%	-1,540.40%	15.09%	-5.41%	3.86%	80.74%	92.85%	2,022.04%	-639.56%	32.26%
Invested Capital Q/Q Growth	-3.12%	22.79%	1.60%	3.65%	-3.41%	4.45%	-1.27%	-0.52%	23.48%	-2.39%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	46.34%	42.64%	45.24%	44.67%	44.06%	42.69%	44.65%	45.44%	44.34%	42.54%
EBITDA Margin	32.34%	25.79%	27.12%	27.11%	39.58%	24.26%	25.57%	28.18%	26.13%	25.33%
Operating Margin	24.54%	21.59%	22.75%	23.65%	22.64%	20.34%	20.14%	22.63%	21.05%	19.16%
EBIT Margin	28.88%	21.66%	22.82%	22.67%	34.72%	19.24%	20.47%	23.20%	20.63%	19.46%
Profit (Net Income) Margin	21.69%	16.04%	16.54%	16.37%	26.34%	13.73%	15.15%	17.49%	14.90%	14.28%
Tax Burden Percent	78.24%	79.51%	77.75%	77.59%	79.83%	77.25%	78.51%	78.79%	77.01%	81.48%
Interest Burden Percent	95.97%	93.11%	93.21%	93.07%	95.03%	92.36%	94.26%	95.68%	93.75%	90.05%
Effective Tax Rate	21.76%	20.49%	22.25%	22.41%	20.17%	22.75%	21.49%	21.21%	22.99%	18.52%
Return on Invested Capital (ROIC)	18.20%	14.96%	15.36%	15.63%	15.77%	12.10%	11.99%	13.16%	10.89%	10.67%
ROIC Less NNEP Spread (ROIC-NNEP)	22.39%	13.70%	13.99%	13.71%	25.40%	10.47%	11.36%	12.84%	9.98%	9.64%
Return on Net Nonoperating Assets (RNNOA)	3.97%	3.43%	3.23%	3.94%	5.59%	3.06%	2.77%	3.17%	3.19%	2.93%
Return on Equity (ROE)	22.17%	18.38%	18.59%	19.57%	21.36%	15.16%	14.76%	16.33%	14.08%	13.60%
Cash Return on Invested Capital (CROIC)	11.29%	-9.75%	-6.38%	-7.01%	-6.56%	7.44%	9.74%	13.38%	-12.51%	-5.65%
Operating Return on Assets (OROA)	18.29%	13.22%	14.03%	14.18%	21.67%	11.07%	11.45%	12.74%	10.43%	10.09%
Return on Assets (ROA)	13.73%	9.78%	10.17%	10.24%	16.44%	7.90%	8.47%	9.60%	7.53%	7.40%
Return on Common Equity (ROCE)	22.17%	18.38%	18.59%	19.57%	21.36%	15.16%	14.76%	16.33%	14.08%	13.60%
Return on Equity Simple (ROE_SIMPLE)	20.53%	0.00%	18.17%	17.90%	18.23%	0.00%	15.95%	15.87%	12.82%	0.00%
Net Operating Profit after Tax (NOPAT)	158	139	150	155	143	124	127	144	129	135
NOPAT Margin	19.20%	17.16%	17.69%	18.35%	18.07%	15.72%	15.81%	17.83%	16.21%	15.61%
Net Nonoperating Expense Percent (NNEP)	-4.18%	1.25%	1.37%	1.92%	-9.63%	1.63%	0.63%	0.32%	0.91%	1.03%
Return On Investment Capital (ROIC_SIMPLE)	-	3.09%	-	-	-	2.55%	-	-	-	2.34%
Cost of Revenue to Revenue	53.67%	57.36%	54.76%	55.33%	55.94%	57.31%	55.35%	54.56%	55.66%	57.46%
SG&A Expenses to Revenue	19.65%	20.85%	22.44%	20.60%	20.91%	22.01%	24.37%	22.65%	22.91%	22.93%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	21.80%	21.06%	22.50%	21.02%	21.43%	22.35%	24.51%	22.81%	23.29%	23.39%
Earnings before Interest and Taxes (EBIT)	238	176	193	192	276	152	164	187	165	168
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	267	209	229	229	314	191	205	228	209	219
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	5.25	5.51	5.30	4.89	4.57	4.56	5.07	4.15	4.24	4.16
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	4.77	5.26	5.23	4.82	4.70	4.94	5.68	4.76	5.07	4.83
Price to Earnings (P/E)	25.57	28.54	29.19	27.28	25.07	27.11	31.74	26.15	33.00	31.28
Dividend Yield	1.17%	1.05%	1.06%	1.15%	1.21%	1.18%	1.06%	1.62%	1.24%	1.30%
Earnings Yield	3.91%	3.50%	3.43%	3.67%	3.99%	3.69%	3.15%	3.82%	3.03%	3.20%
Enterprise Value to Invested Capital (EV/IC)	4.54	4.31	4.32	3.92	3.87	3.87	4.40	3.67	3.32	3.30
Enterprise Value to Revenue (EV/Rev)	4.94	5.59	5.52	5.12	4.93	5.18	5.90	4.95	5.52	5.24
Enterprise Value to EBITDA (EV/EBITDA)	17.08	19.55	19.63	18.23	16.54	17.58	20.27	16.82	21.18	19.94
Enterprise Value to EBIT (EV/EBIT)	19.60	22.52	22.80	21.34	19.43	20.87	24.32	20.26	26.40	25.06
Enterprise Value to NOPAT (EV/NOPAT)	26.50	30.24	30.53	28.28	27.59	29.54	34.58	29.26	33.63	32.06
Enterprise Value to Operating Cash Flow (EV/OCF)	27.54	31.91	28.91	26.02	23.77	23.65	26.25	21.98	25.31	25.65
Enterprise Value to Free Cash Flow (EV/FCFF)	41.44	0.00	0.00	0.00	0.00	53.56	45.93	27.27	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.43	0.48	0.46	0.45	0.39	0.37	0.37	0.36	0.54	0.52
Long-Term Debt to Equity	0.43	0.48	0.46	0.45	0.39	0.37	0.37	0.36	0.54	0.49
Financial Leverage	0.18	0.25	0.23	0.29	0.22	0.29	0.24	0.25	0.32	0.30
Leverage Ratio	1.76	1.79	1.74	1.75	1.71	1.73	1.69	1.68	1.75	1.72
Compound Leverage Factor	1.69	1.66	1.62	1.63	1.62	1.60	1.59	1.60	1.64	1.55
Debt to Total Capital	29.82%	32.58%	31.29%	30.98%	28.07%	27.24%	26.78%	26.21%	35.22%	34.07%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	1.75%
Long-Term Debt to Total Capital	29.82%	32.58%	31.29%	30.97%	28.05%	27.23%	26.77%	26.20%	35.21%	32.32%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	-0.01%	0.01%	0.01%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%
Common Equity to Total Capital	70.18%	67.42%	68.70%	69.01%	71.93%	72.77%	73.22%	73.79%	64.79%	65.95%
Debt to EBITDA	1.34	1.61	1.60	1.58	1.35	1.38	1.41	1.38	2.49	2.28
Net Debt to EBITDA	0.57	1.14	1.04	1.09	0.77	0.82	0.75	0.64	1.73	1.56
Long-Term Debt to EBITDA	1.34	1.61	1.60	1.58	1.35	1.37	1.41	1.38	2.49	2.16
Debt to NOPAT	2.07	2.50	2.48	2.44	2.25	2.31	2.40	2.41	3.96	3.67
Net Debt to NOPAT	0.89	1.77	1.62	1.69	1.29	1.38	1.28	1.11	2.75	2.51
Long-Term Debt to NOPAT	2.07	2.50	2.48	2.44	2.24	2.31	2.40	2.41	3.96	3.48
Altman Z-Score	6.28	5.83	6.05	5.75	5.99	5.95	6.67	5.90	4.65	4.83
Noncontrolling Interest Sharing Ratio	0.00%	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.23	2.57	3.10	3.06	3.11	2.89	3.37	3.41	2.97	2.53
Quick Ratio	2.15	1.61	1.95	1.87	2.04	1.92	2.29	2.36	1.96	1.73
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-49	-805	-684	-721	-693	-133	-9.54	183	-989	-670
Operating Cash Flow to CapEx	1,215.34%	836.50%	556.02%	653.70%	1,127.36%	930.56%	783.00%	840.25%	1,498.54%	1,113.55%
Free Cash Flow to Firm to Interest Expense	-5.11	0.00	-52.19	-54.18	-50.57	0.00	-1.01	22.64	-96.05	0.00
Operating Cash Flow to Interest Expense	20.64	0.00	11.29	10.62	16.54	0.00	16.66	16.49	19.93	0.00
Operating Cash Flow Less CapEx to Interest Expense	18.94	0.00	9.26	8.99	15.07	0.00	14.53	14.53	18.60	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.63	0.61	0.61	0.63	0.62	0.58	0.56	0.55	0.51	0.52
Accounts Receivable Turnover	7.99	7.96	7.64	7.55	7.88	7.52	7.30	7.24	7.05	7.32
Inventory Turnover	4.18	4.17	3.91	3.91	4.08	4.10	3.91	3.91	3.81	4.29
Fixed Asset Turnover	9.98	8.97	9.07	8.93	9.09	8.06	7.83	7.59	7.18	7.34
Accounts Payable Turnover	9.08	9.05	8.49	9.10	9.87	9.40	9.00	9.83	9.21	9.66
Days Sales Outstanding (DSO)	45.71	45.84	47.78	48.33	46.33	48.53	49.99	50.42	51.74	49.90
Days Inventory Outstanding (DIO)	87.36	87.49	93.41	93.31	89.46	89.07	93.27	93.37	95.85	85.12
Days Payable Outstanding (DPO)	40.21	40.32	42.99	40.12	36.99	38.82	40.58	37.14	39.65	37.78
Cash Conversion Cycle (CCC)	92.85	93.01	98.20	101.52	98.80	98.79	102.68	106.66	107.94	97.23
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,358	4,124	4,190	4,342	4,195	4,381	4,326	4,303	5,313	5,186
Invested Capital Turnover	0.95	0.87	0.87	0.85	0.87	0.77	0.76	0.74	0.67	0.68
Increase / (Decrease) in Invested Capital	207	944	833	876	836	257	136	-39	1,119	805
Enterprise Value (EV)	15,233	17,789	18,085	17,032	16,237	16,949	19,042	15,775	17,627	17,137
Market Capitalization	14,723	16,750	17,125	16,017	15,478	16,158	18,335	15,178	16,185	15,798
Book Value per Share	$37.14	$40.30	$42.76	$43.38	$44.80	$46.83	$47.80	$48.27	$50.45	$50.11
Tangible Book Value per Share	($0.23)	($7.25)	($4.80)	($5.20)	($2.78)	($4.08)	($2.03)	($0.85)	($11.18)	($9.80)
Total Capital	3,994	4,508	4,700	4,751	4,709	4,867	4,942	4,951	5,894	5,754
Total Debt	1,191	1,469	1,471	1,472	1,322	1,326	1,324	1,298	2,076	1,960
Total Long-Term Debt	1,191	1,469	1,471	1,472	1,321	1,325	1,323	1,297	2,075	1,860
Net Debt	510	1,039	960	1,015	759	791	707	597	1,443	1,339
Capital Expenditures (CapEx)	16	20	27	22	20	22	20	16	14	16
Debt-free, Cash-free Net Working Capital (DFCFNWC)	448	426	522	545	469	412	478	452	481	443
Debt-free Net Working Capital (DFNWC)	1,129	856	1,033	1,002	1,031	947	1,095	1,153	1,114	1,064
Net Working Capital (NWC)	1,129	856	1,033	1,001	1,031	946	1,094	1,152	1,113	963
Net Nonoperating Expense (NNE)	-20	9.14	9.72	17	-66	16	5.26	2.76	10	11
Net Nonoperating Obligations (NNO)	556	1,084	960	1,064	807	840	707	650	1,495	1,392
Total Depreciation and Amortization (D&A)	29	34	36	38	39	40	41	40	44	51
Debt-free, Cash-free Net Working Capital to Revenue	14.51%	13.37%	15.93%	16.38%	14.22%	12.59%	14.81%	14.17%	15.04%	13.55%
Debt-free Net Working Capital to Revenue	36.57%	26.89%	31.52%	30.12%	31.30%	28.91%	33.90%	36.13%	34.86%	32.54%
Net Working Capital to Revenue	36.57%	26.89%	31.52%	30.10%	31.27%	28.90%	33.88%	36.12%	34.84%	29.46%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.37	$1.71	$1.85	$1.83	$2.76	$1.43	$1.60	$1.86	$1.57	$1.63
Adjusted Weighted Average Basic Shares Outstanding	75.40M	75.70M	75.60M	75.60M	75.60M	75.60M	75.70M	75.70M	75.70M	75.70M
Adjusted Diluted Earnings per Share	$2.36	$1.71	$1.84	$1.82	$2.75	$1.44	$1.60	$1.86	$1.57	$1.61
Adjusted Weighted Average Diluted Shares Outstanding	75.80M	76M	75.90M	75.90M	75.90M	75.90M	75.90M	75.90M	75.90M	75.90M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	75.42M	75.52M	75.58M	75.60M	75.63M	75.64M	75.70M	75.70M	75.72M	75.78M
Normalized Net Operating Profit after Tax (NOPAT)	172	140	150	158	147	126	127	145	132	138
Normalized NOPAT Margin	20.88%	17.33%	17.73%	18.68%	18.48%	15.98%	15.92%	17.96%	16.50%	15.98%
Pre Tax Income Margin	27.72%	20.17%	21.27%	21.09%	33.00%	17.77%	19.30%	22.20%	19.34%	17.52%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	24.79	0.00	14.73	14.42	20.11	0.00	17.44	23.12	15.99	0.00
NOPAT to Interest Expense	16.48	0.00	11.41	11.67	10.47	0.00	13.46	17.77	12.56	0.00
EBIT Less CapEx to Interest Expense	23.09	0.00	12.69	12.80	18.64	0.00	15.31	21.16	14.66	0.00
NOPAT Less CapEx to Interest Expense	14.78	0.00	9.38	10.05	9.00	0.00	11.34	15.81	11.23	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	30.07%	30.24%	30.94%	31.41%	30.37%	32.02%	33.56%	34.06%	41.13%	40.69%
Augmented Payout Ratio	55.49%	55.48%	30.94%	38.01%	30.84%	36.08%	33.56%	38.06%	45.84%	40.69%

Frequently Asked Questions About IDEX's Financials

When does IDEX's financial year end?

According to the most recent income statement we have on file, IDEX's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has IDEX's net income changed over the last 9 years?

IDEX's net income appears to be on an upward trend, with a most recent value of $504.60 million in 2024, rising from $282.81 million in 2015. The previous period was $595.60 million in 2023. Check out IDEX's forecast to explore projected trends and price targets.

What is IDEX's operating income?

IDEX's total operating income in 2024 was $677.20 million, based on the following breakdown:

Total Gross Profit: $1.45 billion
Total Operating Expenses: $768 million

How has IDEX revenue changed over the last 9 years?

Over the last 9 years, IDEX's total revenue changed from $2.02 billion in 2015 to $3.27 billion in 2024, a change of 61.8%.

How much debt does IDEX have?

IDEX's total liabilities were at $2.95 billion at the end of 2024, a 27.0% increase from 2023, and a 116.7% increase since 2015.

How much cash does IDEX have?

In the past 9 years, IDEX's cash and equivalents has ranged from $235.96 million in 2016 to $1.03 billion in 2020, and is currently $620.80 million as of their latest financial filing in 2024.

How has IDEX's book value per share changed over the last 9 years?

Over the last 9 years, IDEX's book value per share changed from 18.86 in 2015 to 50.11 in 2024, a change of 165.7%.

Related Companies

This page (NYSE:IEX) was last updated on 5/5/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IDEX (IEX) Financials

Frequently Asked Questions About IDEX's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

IDEX (IEX) Financials

Annual Income Statements for IDEX

Quarterly Income Statements for IDEX

Annual Cash Flow Statements for IDEX

Quarterly Cash Flow Statements for IDEX

Annual Balance Sheets for IDEX

Quarterly Balance Sheets for IDEX

Annual Metrics and Ratios for IDEX

Quarterly Metrics and Ratios for IDEX

Frequently Asked Questions About IDEX's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools